Cargando…

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy

Left ventricular hypertrophy (LVH) is a pivotal manifestation of hypertensive organ damage associated with an increased cardiovascular risk. However, early diagnostic biomarkers for assessing LVH in patients with hypertension (HT) remain indefinite. Here, multiple bioinformatics tools combined with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tiegang, Wang, Weiqi, Gan, Wenqiang, Lv, Silin, Zeng, Zifan, Hou, Yufang, Yan, Zheng, Zhang, Rixin, Yang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876903/ https://www.ncbi.nlm.nih.gov/pubmed/35157609 http://dx.doi.org/10.18632/aging.203894

Ejemplares similares

Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer
por: Hou, Yufang, et al.
Publicado: (2022)

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis
por: Zhang, Rixin, et al.
Publicado: (2020)

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma
por: Gan, Wenqiang, et al.
Publicado: (2022)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
por: Zhou, Mingxuan, et al.
Publicado: (2022)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023)

A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019
por: Wang, Weiqi, et al.
Publicado: (2020)

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
por: Zhang, Fang, et al.
Publicado: (2023)

Deficiency of Tregs in hypertension‐associated left ventricular hypertrophy
por: Tang, Ying, et al.
Publicado: (2023)

Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis
por: Al-Hilali, N., et al.
Publicado: (2009)

Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review
por: Woroniecki, Robert P., et al.
Publicado: (2017)

Combined superposition effect of hypertension and dyslipidemia on left ventricular hypertrophy
por: Zhang, Xueyao, et al.
Publicado: (2022)

Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Left ventricular hypertrophy in hypertension: Need of ethnic‐specific criteria
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?
por: Nadarajah, R., et al.
Publicado: (2021)

Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy: Common therapeutic target for left and right ventricular hypertrophy
por: Chen, Lu, et al.
Publicado: (2023)

Left Ventricular Mass Formulae and Prevalence Rates of Echocardiographic Left Ventricular Hypertrophy in Nigerians with Essential Hypertension
por: Adekunle, Ajayi Ebenezer, et al.
Publicado: (2013)

Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy
por: Lin, Chin-Yu, et al.
Publicado: (2015)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians
por: Adebiyi, Adewole A, et al.
Publicado: (2006)

Expression of circulating micro-RNAs in hypertensive patients with left ventricular hypertrophy
por: Zi Ling, Soh, et al.
Publicado: (2012)

Serum apelin is associated with left ventricular hypertrophy in untreated hypertension patients
por: Ye, Lijun, et al.
Publicado: (2015)

Left ventricular hypertrophy and diastolic function in children and adolescents with essential hypertension
por: Lee, Heirim, et al.
Publicado: (2015)

Commentary: Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review
por: Perez Fernandez, Guillermo A.
Publicado: (2017)

Left ventricular hypertrophy and proteinuria in patients with essential hypertension in Andkhoy, Afghanistan
por: Shoaib Hamrah, Mohammad, et al.
Publicado: (2018)

Pseudo-Wellens Syndrome in a Patient with Hypertension and Left Ventricular Hypertrophy
por: Ola, Olatunde, et al.
Publicado: (2019)

Association of Hypertensive Intracerebral Hemorrhage with Left Ventricular Hypertrophy on Transthoracic Echocardiography
por: Pallesen, Lars-Peder, et al.
Publicado: (2020)

Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation
por: Angeli, Fabio, et al.
Publicado: (2019)

The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophy
por: Le, Thu-Thao, et al.
Publicado: (2020)

Left ventricular hypertrophy and incident cognitive decline in older adults with hypertension
por: Xu, Ying, et al.
Publicado: (2022)

Role of Osteoprotegerin and Its Gene Polymorphisms in the Occurrence of Left Ventricular Hypertrophy in Essential Hypertensive Patients
por: Shen, Anna, et al.
Publicado: (2014)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block
por: Burgos, Paula Freitas Martins, et al.
Publicado: (2017)

Catheter-Based Radiofrequency Renal Sympathetic Denervation Decreases Left Ventricular Hypertrophy in Hypertensive Dogs
por: Tu, Shan, et al.
Publicado: (2021)

Quantifying myocardial fibrosis in hypertensive left ventricular hypertrophy using T1 mapping
por: Janardhanan, Rajesh, et al.
Publicado: (2012)

Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy
por: Li, Xin, et al.
Publicado: (2013)

The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive Patients
por: Xue, Hao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lcbe7he1n92f930hqkt49sjfhk